CD47 stabilizes ROBO2 to regulate glioblastoma progression by preventing ITCH-mediated ubiquitination.

Saved in:
Bibliographic Details
Title: CD47 stabilizes ROBO2 to regulate glioblastoma progression by preventing ITCH-mediated ubiquitination.
Authors: Polara R; Centre for Cancer Biology, College of Health, Adelaide University and SA Pathology, Adelaide, SA 5001, Australia., Gliddon BL; Centre for Cancer Biology, College of Health, Adelaide University and SA Pathology, Adelaide, SA 5001, Australia., Ganesan R; Centre for Cancer Biology, College of Health, Adelaide University and SA Pathology, Adelaide, SA 5001, Australia.; Cologne Cluster of Excellence in Cellular Stress Responses in Aging-Associated Diseases, University Clinic Cologne, Cologne 50931, Germany., Davies LT; Centre for Cancer Biology, College of Health, Adelaide University and SA Pathology, Adelaide, SA 5001, Australia., Toubia J; Centre for Cancer Biology, College of Health, Adelaide University and SA Pathology, Adelaide, SA 5001, Australia.; Data and Bioinformatics Innovation, Department of Genetics and Molecular Pathology, SA Pathology, Adelaide, SA 5000, Australia., Lenin S; Centre for Cancer Biology, College of Health, Adelaide University and SA Pathology, Adelaide, SA 5001, Australia., Siddiqui G; Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville Campus, Parkville, VIC 3052, Australia., Morris-Hanon O; Centre for Cancer Biology, College of Health, Adelaide University and SA Pathology, Adelaide, SA 5001, Australia., Tea MN; Centre for Cancer Biology, College of Health, Adelaide University and SA Pathology, Adelaide, SA 5001, Australia., Moretti PAB; Centre for Cancer Biology, College of Health, Adelaide University and SA Pathology, Adelaide, SA 5001, Australia., Nguyen DA; Centre for Cancer Biology, College of Health, Adelaide University and SA Pathology, Adelaide, SA 5001, Australia., Kok CH; Centre for Cancer Biology, College of Health, Adelaide University and SA Pathology, Adelaide, SA 5001, Australia.; Data and Bioinformatics Innovation, Department of Genetics and Molecular Pathology, SA Pathology, Adelaide, SA 5000, Australia.; School of Medicine, College of Health, Adelaide University, Adelaide, SA 5000, Australia., Shard C; Centre for Cancer Biology, College of Health, Adelaide University and SA Pathology, Adelaide, SA 5001, Australia., Staudacher AH; Centre for Cancer Biology, College of Health, Adelaide University and SA Pathology, Adelaide, SA 5001, Australia.; School of Medicine, College of Health, Adelaide University, Adelaide, SA 5000, Australia., Brown MP; Centre for Cancer Biology, College of Health, Adelaide University and SA Pathology, Adelaide, SA 5001, Australia.; School of Medicine, College of Health, Adelaide University, Adelaide, SA 5000, Australia.; Cancer Clinical Trials Unit, Royal Adelaide Hospital, Adelaide, SA 5000, Australia., Creek DJ; Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville Campus, Parkville, VIC 3052, Australia., Gomez GA; Centre for Cancer Biology, College of Health, Adelaide University and SA Pathology, Adelaide, SA 5001, Australia., Thomas D; School of Medicine, College of Health, Adelaide University, Adelaide, SA 5000, Australia.; Precision Cancer Medicine Theme, South Australian Health and Medical Research Institute, Adelaide, SA 5001, Australia.; Department of Hematology and Bone Marrow Transplantation, Royal Adelaide Hospital, Adelaide, SA 5000, Australia., Pitson SM; Centre for Cancer Biology, College of Health, Adelaide University and SA Pathology, Adelaide, SA 5001, Australia.; School of Medicine, College of Health, Adelaide University, Adelaide, SA 5000, Australia.; School of Biological Sciences, College of Science, Adelaide University, Adelaide, SA 5005, Australia., Robinson N; Centre for Cancer Biology, College of Health, Adelaide University and SA Pathology, Adelaide, SA 5001, Australia.; School of Medicine, College of Health, Adelaide University, Adelaide, SA 5000, Australia.
Source: Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2026 Mar 31; Vol. 123 (13), pp. e2602460123. Date of Electronic Publication: 2026 Mar 23.
Publication Type: Journal Article
Journal Info: Publisher: National Academy of Sciences Country of Publication: United States NLM ID: 7505876 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1091-6490 (Electronic) Linking ISSN: 00278424 NLM ISO Abbreviation: Proc Natl Acad Sci U S A Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1091-6490
DOI:10.1073/pnas.2602460123